Loading
Barcelona breast oncologist who leads SOLTI, the Spanish academic breast cancer research group, and co-authors pivotal endocrine therapy trials.
Mafalda Oliveira is President of SOLTI Cancer Research Group, the Spanish academic cooperative group focused on breast cancer clinical and translational research. A medical oncologist at Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology in Barcelona, she has been an investigator on major trials of novel endocrine and targeted agents in hormone receptor-positive breast cancer, including CAPItello-291 and SERENA-2. Her role is listed on SOLTI's board page.
Shares SOLTI Cancer Research Group, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer, clinical trials.
Shares HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer, clinical trials.
Shares HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer, clinical trials.
Shares HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.